NEULANDLAB.BO
Healthcare Drug Manufacturers - Specialty & GenericNeuland Laboratories Limited
₹21,933.95
+42.30 +0.19% today
Price History
Not enough data
Key Stats
Market Cap
281.41B
Avg Volume
3,972
P/E (TTM)
56.63
EPS
₹387.35
52W High
₹24,235.05
52W Low
₹11,500.00
Div. Yield
0.0%
Analyst Ratings
Buy0
Str Buy
4
Buy
0
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
44.69
P/B Ratio
15.01
P/S Ratio
11.86
EV/EBITDA
37.52
EV/Revenue
11.94
Margins
Gross Margin 55.2%
Operating Margin 30.6%
Net Margin 21.0%
EBITDA Margin 31.8%
Growth & Returns
Revenue Growth (YoY)
119.2%
Earnings Growth (YoY)
962.8%
Earnings Growth (QoQ)
962.4%
Liquidity & Leverage
Debt / Equity
0.16
Total Cash
766.70M
Total Debt
3.01B
About
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
www.neulandlabs.com